[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fl6atqQQLuinh3YkqQlXBmQOM7g7DgIecQymR4IMvn4Q":3},{"id":4,"source":5,"question":6,"options":7,"answer":13,"related":14,"type":21,"origin":96,"createTime":23},303682283,"v1","验证药物对目标适应证患者的治疗作用和安全性指的是",[8,9,10,11,12],"Ⅲ期临床试验","Ⅱ期临床试验","Ⅰ期临床试验","Ⅳ期临床试验","Ⅴ期临床试验",[],[15,24,35,39,50,56,67,73,79,90],{"id":16,"source":5,"question":17,"options":18,"answer":19,"related":20,"type":21,"origin":22,"createTime":23},303682281,"对目标适应证患者(多中心试验)治疗作用的初步评价的是",[12,10,8,9,11],[],[],0,null,"2026-01-05T20:52:22+08:00",{"id":25,"source":5,"question":26,"options":27,"answer":33,"related":34,"type":21,"origin":22,"createTime":23},303682282,"上市前药物临床评价阶段的临床试验可分为",[28,29,30,31,32],"5期","3期","4期","1期","2期",[],[],{"id":4,"source":5,"question":6,"options":36,"answer":37,"related":38,"type":21,"origin":22,"createTime":23},[8,9,10,11,12],[],[],{"id":40,"source":5,"question":41,"options":42,"answer":48,"related":49,"type":21,"origin":22,"createTime":23},303682284,"四期临床试验的局限性,Ⅱ期临床试验中\"低于1%发生频率\"的不良反应很难发现的原因是",[43,44,45,46,47],"试验对象有局限","病例数目少","考察不全面","观察时间短","管理漏洞",[],[],{"id":51,"source":5,"question":52,"options":53,"answer":54,"related":55,"type":21,"origin":22,"createTime":23},303682285,"初步的临床药理学及人体安全性评价是",[12,8,10,9,11],[],[],{"id":57,"source":5,"question":58,"options":59,"answer":65,"related":66,"type":21,"origin":22,"createTime":23},303682286,"\"药物治疗的效果不以货币为单位表示,而是用其他量化的方法表达治疗目的,如延长患者生命时间等\"指",[60,61,62,63,64],"最小成本分析","成本-效益分析","成本-效用分析","成本-效果分析","最大效果分析",[],[],{"id":68,"source":5,"question":69,"options":70,"answer":71,"related":72,"type":21,"origin":22,"createTime":23},303682287,"考察药品在广泛使用条件下的疗效和不良反应的是",[12,10,11,8,9],[],[],{"id":74,"source":5,"question":75,"options":76,"answer":77,"related":78,"type":21,"origin":22,"createTime":23},303682288,"四期临床试验的局限性,临床试验观测的指标限于实验设计内容,易忽视其他临床指标是由于",[44,43,46,47,45],[],[],{"id":80,"source":5,"question":81,"options":82,"answer":88,"related":89,"type":21,"origin":22,"createTime":23},303682289,"Ⅳ期临床试验样本数为",[83,84,85,86,87],"主要病种≥300例","20~30例","≥300例","多发病≥300例,其中主要病种≥100例","常见病≥2000例",[],[],{"id":91,"source":5,"question":92,"options":93,"answer":94,"related":95,"type":21,"origin":22,"createTime":23},303682290,"四期临床试验的局限性,不能发现\"长时间应用才能发生或停药后迟发\"的药品不良反应是因为",[44,46,47,45,43],[],[],{"courseName":97,"courseImg":98,"workName":99,"workId":99,"count":21,"courseId":100},"默认课程","https:\u002F\u002Ftihai-oss-cloud.itihey.com\u002Fimg\u002F03a579384a6dc297c89809b582fcc767.png","","53e1d2ef4961cca8eea3e23969ad2cb9"]